[go: up one dir, main page]

ES521588A0 - Procedimiento de obtencion de nuevas n-ciano-formamidinas. - Google Patents

Procedimiento de obtencion de nuevas n-ciano-formamidinas.

Info

Publication number
ES521588A0
ES521588A0 ES521588A ES521588A ES521588A0 ES 521588 A0 ES521588 A0 ES 521588A0 ES 521588 A ES521588 A ES 521588A ES 521588 A ES521588 A ES 521588A ES 521588 A0 ES521588 A0 ES 521588A0
Authority
ES
Spain
Prior art keywords
ciano
formamidines
procedure
obtaining new
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521588A
Other languages
English (en)
Other versions
ES8407016A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to ES521588A priority Critical patent/ES8407016A1/es
Priority to ZA841477A priority patent/ZA841477B/xx
Priority to US06/595,662 priority patent/US4600780A/en
Priority to EP84103490A priority patent/EP0123920B1/en
Priority to DE8484103490T priority patent/DE3461376D1/de
Priority to JP59061316A priority patent/JPS59216875A/ja
Priority to PH30480A priority patent/PH20916A/en
Publication of ES521588A0 publication Critical patent/ES521588A0/es
Publication of ES8407016A1 publication Critical patent/ES8407016A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
ES521588A 1983-03-30 1983-03-30 Procedimiento de obtencion de nuevas n-ciano-formamidinas. Expired ES8407016A1 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES521588A ES8407016A1 (es) 1983-03-30 1983-03-30 Procedimiento de obtencion de nuevas n-ciano-formamidinas.
ZA841477A ZA841477B (en) 1983-03-30 1984-02-28 N-cyano-formamidines and processes for their production
US06/595,662 US4600780A (en) 1983-03-30 1984-03-20 N-cyano-formamidines
EP84103490A EP0123920B1 (en) 1983-03-30 1984-03-29 N-cyano-formamidine compounds, process for preparing them and pharmaceutical compositions containing them
DE8484103490T DE3461376D1 (en) 1983-03-30 1984-03-29 N-cyano-formamidine compounds, process for preparing them and pharmaceutical compositions containing them
JP59061316A JPS59216875A (ja) 1983-03-30 1984-03-30 新規ｎ−シアノ−ホルムアミジン、その製法及びこれを含有するヒスタミンｈ↓２−レセプタ−「きつ」抗剤
PH30480A PH20916A (en) 1983-03-30 1984-03-30 New n-cyano formamidines and process for their production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES521588A ES8407016A1 (es) 1983-03-30 1983-03-30 Procedimiento de obtencion de nuevas n-ciano-formamidinas.

Publications (2)

Publication Number Publication Date
ES521588A0 true ES521588A0 (es) 1984-08-16
ES8407016A1 ES8407016A1 (es) 1984-08-16

Family

ID=8485597

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521588A Expired ES8407016A1 (es) 1983-03-30 1983-03-30 Procedimiento de obtencion de nuevas n-ciano-formamidinas.

Country Status (7)

Country Link
US (1) US4600780A (es)
EP (1) EP0123920B1 (es)
JP (1) JPS59216875A (es)
DE (1) DE3461376D1 (es)
ES (1) ES8407016A1 (es)
PH (1) PH20916A (es)
ZA (1) ZA841477B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4158013A (en) * 1977-06-03 1979-06-12 Bristol-Myers Company N-Cyano-N'-alkynyl-N"-2-mercaptoethylguanidines
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd

Also Published As

Publication number Publication date
EP0123920A1 (en) 1984-11-07
JPS59216875A (ja) 1984-12-06
ZA841477B (en) 1984-09-26
EP0123920B1 (en) 1986-11-20
US4600780A (en) 1986-07-15
DE3461376D1 (en) 1987-01-08
ES8407016A1 (es) 1984-08-16
PH20916A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
FI842889A0 (fi) Partikelsuspensioner foer immunoglutination.
DE3480953D1 (de) Testverfahren.
NO820795L (no) Fremgangsmaate for mikroinnkapsling.
FI842467A (fi) Anordning foer framstaellning av traeslip .
FI842621A (fi) Skidbindning speciellt foer terraengskidning.
FI852443A0 (fi) Anordning foer framstaellning av en roerformig behaollarhylsa.
ES536780A0 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
ES521865A0 (es) Procedimiento de producir derivados oxazolicos.
IT8423765A0 (it) Procedimento per produrre 4-alcossianiline.
ES532240A0 (es) Procedimiento para la obtencion de benzoil-ureas.
FI843073A (fi) Anordning foer avtagande av stoevlar.
FI834289A (fi) Medbringare foer en draganordning.
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
ES532635A0 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
AR240451A1 (es) Procedimiento para la obtenicon de pirrolidinonas.
FI853053A0 (fi) Anordning foer framstaellning av flerkomponentsblandningar.
NO157221C (no) Fremgangsmaate for elektroplettering.
ES533691A0 (es) Procedimiento de preparar 2,9-dihidrofuranos
ES521720A0 (es) Procedimiento de obtencion de nuevas carboxamidoguanidinas.
ES521588A0 (es) Procedimiento de obtencion de nuevas n-ciano-formamidinas.
ES531766A0 (es) Procedimiento para la obtencion de benzofuranonas.
ES519297A0 (es) Procedimiento de obtencion de nuevas 1,2-oxazetidinas.
ES531764A0 (es) Procedimiento de obtencion de nuevas sulfonamidinas.
ES519930A0 (es) Procedimiento para la obtencion de n-alquiloxialquil-acetanilidas.
AR231435A1 (es) Procedimiento de obtencion de-2-cloro-2,6-dietil-n-metoxi-metil-acetanilida